Ginsenoside Rh2 alleviates inflammatory response and enhances motor function recovery in spinal cord injury mice via the ROS/MAPK14 signaling pathway. [PDF]
Wu Y +14 more
europepmc +1 more source
The molecular mechanism of ginsenoside Rh2 and its octyl ester derivative on anti-angiogenesis in cancer treatment: The battle between PI3K and ROS. [PDF]
Hu QR +8 more
europepmc +1 more source
20(S)-Ginsenoside Rh2 inhibits hepatocellular carcinoma by suppressing angiogenesis and the GPC3-mediated Wnt/β‑catenin signaling pathway. [PDF]
Xu L, Li J, Hou N, Han F, Sun X, Li Q.
europepmc +1 more source
Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy. [PDF]
Hong C +10 more
europepmc +1 more source
Ginsenoside Rh2 suppresses ferroptosis in ulcerative colitis by targeting specific protein 1 by upregulating microRNA-125a-5p. [PDF]
Zhao X, Yuan W, Yang L, Yan F, Cui D.
europepmc +1 more source
20(S)-Ginsenoside Rh2 overcomes gemcitabine resistance in pancreatic cancer by inhibiting LAMC2-Modulated ABC transporters. [PDF]
Wu Y +6 more
europepmc +1 more source
20(S)-Ginsenoside Rh2 induces apoptosis and autophagy in melanoma cells via suppressing Src/STAT3 signaling. [PDF]
Li JK +7 more
europepmc +1 more source
20(S)-ginsenoside Rh2 ameliorates ATRA resistance in APL by modulating lactylation-driven METTL3. [PDF]
Cheng S +11 more
europepmc +1 more source
Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer. [PDF]
Liu X, Li J, Huang Q, Jin M, Huang G.
europepmc +1 more source
Ginsenoside Rh2 Alleviates LPS-Induced Inflammatory Responses by Binding to TLR4/MD-2 and Blocking TLR4 Dimerization. [PDF]
Pan S +6 more
europepmc +1 more source

